Seeking Alpha

More on Baxter (BAX) / Gambro deal: the acquisition, Baxter's largest ever, combines the second...

More on Baxter (BAX) / Gambro deal: the acquisition, Baxter's largest ever, combines the second and third largest manufacturers of dialysis equipment, so it could arouse antitrust concerns. Baxter expects synergies of $300M a year by 2017, but says the deal will cut adjusted EPS by $0.10-$0.15 next year and be neutral or add to earnings in 2014, and then add to profit after that. (Webcast) (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)